ID   SREC2_HUMAN             Reviewed;         870 AA.
AC   Q96GP6; E5RFB8; Q58A83; Q8IXF3; Q9BW74;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2012, sequence version 4.
DT   10-MAY-2017, entry version 140.
DE   RecName: Full=Scavenger receptor class F member 2;
DE   AltName: Full=SRECRP-1;
DE   AltName: Full=Scavenger receptor expressed by endothelial cells 2 protein;
DE            Short=SREC-II;
DE   Flags: Precursor;
GN   Name=SCARF2; Synonyms=SREC2, SREPCR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS SER-174; GLU-777
RP   AND LEU-778.
RA   Adachi H., Tsujimoto M.;
RT   "cDNA cloning of SRECRP (scavenger receptor expressed by endothelial
RT   cell related protein).";
RL   Submitted (DEC-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Epithelium;
RX   PubMed=12154095; DOI=10.1074/jbc.M206140200;
RA   Ishii J., Adachi H., Aoki J., Koizumi H., Tomita S., Suzuki T.,
RA   Tsujimoto M., Inoue K., Arai H.;
RT   "SREC-II, a new member of the scavenger receptor type F family, trans-
RT   interacts with SREC-I through its extracellular domain.";
RL   J. Biol. Chem. 277:39696-39702(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANTS GLU-777 AND
RP   LEU-778.
RC   TISSUE=Vulva;
RA   Kitaura M., Iwagami S., Tsuruta Y., Suzuki R.;
RT   "A novel human nurse cell receptor NSR1.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANTS GLU-777
RP   AND LEU-778.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 272-870 (ISOFORM 2), AND
RP   VARIANTS GLU-777 AND LEU-778.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-651; SER-653 AND
RP   SER-718, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613; SER-653 AND
RP   SER-742, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-499.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [11]
RP   VARIANT VDEGS TYR-258.
RX   PubMed=20887961; DOI=10.1016/j.ajhg.2010.09.005;
RA   Anastasio N., Ben-Omran T., Teebi A., Ha K.C., Lalonde E., Ali R.,
RA   Almureikhi M., Der Kaloustian V.M., Liu J., Rosenblatt D.S.,
RA   Majewski J., Jerome-Majewska L.A.;
RT   "Mutations in SCARF2 are responsible for Van Den Ende-Gupta
RT   syndrome.";
RL   Am. J. Hum. Genet. 87:553-559(2010).
CC   -!- FUNCTION: Probable adhesion protein, which mediates homophilic and
CC       heterophilic interactions. In contrast to SCARF1, it poorly
CC       mediates the binding and degradation of acetylated low density
CC       lipoprotein (Ac-LDL) (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homophilic and heterophilic interaction via its
CC       extracellular domain. Interacts with SCARF1. The heterophilic
CC       interaction with SCARF1, which is stronger than the homophilic
CC       interaction with itself, is suppressed by the presence of SCARF1
CC       ligand such as Ac-LDL (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P16333:NCK1; NbExp=2; IntAct=EBI-1752088, EBI-389883;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96GP6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96GP6-2; Sequence=VSP_042462;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in endothelial cells.
CC       Expressed in heart, placenta, lung, kidney, spleen, small
CC       intestine and ovary. {ECO:0000269|PubMed:12154095}.
CC   -!- DISEASE: Van den Ende-Gupta syndrome (VDEGS) [MIM:600920]: A
CC       syndrome characterized by craniofacial and skeletal abnormalities
CC       that include blepharophimosis, a flat and wide nasal bridge,
CC       narrow and beaked nose, hypoplastic maxilla with or without cleft
CC       palate and everted lower lip, prominent ears, down-slanting eyes,
CC       arachnodactyly, and camptodactyly. Patients present congenital
CC       joint contractures that improve without intervention, and normal
CC       growth and development. Intelligence is normal. Rarely, enlarged
CC       cerebella can be present. Some patients experience respiratory
CC       problems due to laryngeal abnormalities.
CC       {ECO:0000269|PubMed:20887961}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- CAUTION: The conflict at position 750-768 is due to frameshifts.
CC       The frameshifted sequence is found in mouse. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB052951; BAC53753.1; -; mRNA.
DR   EMBL; AF522196; AAN45861.1; -; mRNA.
DR   EMBL; AB024433; BAD93345.1; -; mRNA.
DR   EMBL; AC007731; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471176; EAX02965.1; -; Genomic_DNA.
DR   EMBL; BC000584; AAH00584.2; -; mRNA.
DR   EMBL; BC009326; AAH09326.2; -; mRNA.
DR   RefSeq; NP_699165.3; NM_153334.6.
DR   RefSeq; NP_878315.2; NM_182895.4.
DR   UniGene; Hs.474251; -.
DR   ProteinModelPortal; Q96GP6; -.
DR   SMR; Q96GP6; -.
DR   BioGrid; 124803; 4.
DR   IntAct; Q96GP6; 4.
DR   MINT; MINT-7240909; -.
DR   STRING; 9606.ENSP00000266214; -.
DR   iPTMnet; Q96GP6; -.
DR   PhosphoSitePlus; Q96GP6; -.
DR   SwissPalm; Q96GP6; -.
DR   BioMuta; SCARF2; -.
DR   DMDM; 380865486; -.
DR   PaxDb; Q96GP6; -.
DR   PeptideAtlas; Q96GP6; -.
DR   PRIDE; Q96GP6; -.
DR   DNASU; 91179; -.
DR   Ensembl; ENST00000622235; ENSP00000477564; ENSG00000244486.
DR   GeneID; 91179; -.
DR   KEGG; hsa:91179; -.
DR   UCSC; uc062bsr.1; human. [Q96GP6-1]
DR   CTD; 91179; -.
DR   DisGeNET; 91179; -.
DR   GeneCards; SCARF2; -.
DR   H-InvDB; HIX0213276; -.
DR   HGNC; HGNC:19869; SCARF2.
DR   HPA; HPA035079; -.
DR   MalaCards; SCARF2; -.
DR   MIM; 600920; phenotype.
DR   MIM; 613619; gene.
DR   neXtProt; NX_Q96GP6; -.
DR   Orphanet; 2460; Van den Ende-Gupta syndrome.
DR   PharmGKB; PA134908523; -.
DR   eggNOG; KOG1218; Eukaryota.
DR   eggNOG; ENOG410XQWV; LUCA.
DR   HOGENOM; HOG000015093; -.
DR   HOVERGEN; HBG023166; -.
DR   InParanoid; Q96GP6; -.
DR   PhylomeDB; Q96GP6; -.
DR   TreeFam; TF332598; -.
DR   ChiTaRS; SCARF2; human.
DR   GenomeRNAi; 91179; -.
DR   PRO; PR:Q96GP6; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000244486; -.
DR   CleanEx; HS_SCARF2; -.
DR   ExpressionAtlas; Q96GP6; baseline and differential.
DR   Genevisible; Q96GP6; HS.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_.
DR   InterPro; IPR002049; Laminin_EGF.
DR   InterPro; IPR033327; Scarf2.
DR   PANTHER; PTHR24043:SF15; PTHR24043:SF15; 1.
DR   SMART; SM00181; EGF; 7.
DR   SMART; SM00180; EGF_Lam; 6.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00022; EGF_1; 7.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell adhesion; Complete proteome;
KW   Disease mutation; Disulfide bond; EGF-like domain; Glycoprotein;
KW   Membrane; Phosphoprotein; Polymorphism; Receptor; Reference proteome;
KW   Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     43       {ECO:0000255}.
FT   CHAIN        44    870       Scavenger receptor class F member 2.
FT                                /FTId=PRO_0000007739.
FT   TOPO_DOM     44    441       Extracellular. {ECO:0000255}.
FT   TRANSMEM    442    462       Helical. {ECO:0000255}.
FT   TOPO_DOM    463    870       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       71    110       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      122    153       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      148    182       EGF-like 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      183    212       EGF-like 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      213    241       EGF-like 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      236    270       EGF-like 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      372    403       EGF-like 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   COMPBIAS    648    847       Pro-rich.
FT   MOD_RES     551    551       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P59222}.
FT   MOD_RES     613    613       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     628    628       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P59222}.
FT   MOD_RES     651    651       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     653    653       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     710    710       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P59222}.
FT   MOD_RES     718    718       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     742    742       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD     83     83       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    310    310       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    365    365       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    403    403       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     75     86       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID     80     98       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    100    109       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    126    134       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    128    141       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    143    152       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    156    163       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    158    170       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    172    181       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    185    193       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    187    200       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    202    211       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    215    222       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    217    229       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    231    240       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    244    251       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    246    258       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    260    269       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    376    384       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    379    391       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   DISULFID    393    402       {ECO:0000255|PROSITE-ProRule:PRU00076}.
FT   VAR_SEQ     474    478       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1, ECO:0000303|Ref.3}.
FT                                /FTId=VSP_042462.
FT   VARIANT     174    174       P -> S (in dbSNP:rs361566).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_059274.
FT   VARIANT     258    258       C -> Y (in VDEGS).
FT                                {ECO:0000269|PubMed:20887961}.
FT                                /FTId=VAR_065302.
FT   VARIANT     425    425       T -> S (in dbSNP:rs2241230).
FT                                /FTId=VAR_055776.
FT   VARIANT     499    499       R -> C (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035837.
FT   VARIANT     522    522       H -> L (in dbSNP:rs12484828).
FT                                /FTId=VAR_055777.
FT   VARIANT     777    777       D -> E (in dbSNP:rs759611).
FT                                {ECO:0000269|PubMed:11181995,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015148.
FT   VARIANT     778    778       V -> L (in dbSNP:rs759612).
FT                                {ECO:0000269|PubMed:11181995,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_015149.
FT   VARIANT     819    819       A -> G (in dbSNP:rs874100).
FT                                /FTId=VAR_015150.
FT   VARIANT     837    837       A -> G (in dbSNP:rs874101).
FT                                /FTId=VAR_015151.
FT   CONFLICT    629    641       ARVARREARPARA -> PTTTWITHSTAAS (in Ref.
FT                                6; AAH00584). {ECO:0000305}.
FT   CONFLICT    750    768       AAPRPLGAHGRRRSPAKRA -> GRGPGLLEPTDAGGPPRS
FT                                AP (in Ref. 1; BAC53753, 3; BAD93345, 5;
FT                                EAX02965 and 6; AAH00584/AAH09326).
FT                                {ECO:0000305}.
SQ   SEQUENCE   870 AA;  92479 MW;  DCB735A50E6E9D1F CRC64;
     MEGAGPRGAG PARRRGAGGP PSPLLPSLLL LLLLWMLPDT VAPQELNPRG RNVCRAPGSQ
     VPTCCAGWRQ QGDECGIAVC EGNSTCSENE VCVRPGECRC RHGYFGANCD TKCPRQFWGP
     DCKELCSCHP HGQCEDVTGQ CTCHARRWGA RCEHACQCQH GTCHPRSGAC RCEPGWWGAQ
     CASACYCSAT SRCDPQTGAC LCHAGWWGRS CNNQCACNSS PCEQQSGRCQ CRERTFGARC
     DRYCQCFRGR CHPVDGTCAC EPGYRGKYCR EPCPAGFYGL GCRRRCGQCK GQQPCTVAEG
     RCLTCEPGWN GTKCDQPCAT GFYGEGCSHR CPPCRDGHAC NHVTGKCTRC NAGWIGDRCE
     TKCSNGTYGE DCAFVCADCG SGHCDFQSGR CLCSPGVHGP HCNVTCPPGL HGADCAQACS
     CHEDTCDPVT GACHLETNQR KGVMGAGALL VLLVCLLLSL LGCCCACRGK DPTRRPRPRR
     ELSLGRKKAP HRLCGRFSRI SMKLPRIPLR RQKLPKVVVA HHDLDNTLNC SFLEPPSGLE
     QPSPSWSSRA SFSSFDTTDE GPVYCVPHEE APAESRDPEV PTVPAEAPAP SPVPLTTPAS
     AEEAIPLPAS SDSERSASSV EGPGGALYAR VARREARPAR ARGEIGGLSL SPSPERRKPP
     PPDPATKPKV SWIHGKHSAA AAGRAPSPPP PGSEAAPSPS KRKRTPSDKS AHTVEHGSPR
     TRDPTPRPPG LPEEATALAA PSPPRARARA APRPLGAHGR RRSPAKRAEA ASMLAADVRG
     KTRSLGRAEV ALGAQGPREK PAPPQKAKRS VPPASPARAP PATETPGPEK AATDLPAPET
     PRKKTPIQKP PRKKSREAAG ELGRAGAPTL
//
